Terms: = Lymphoma AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
347 results:
1. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::bcl3 identified by G-banding and fluorescence in situ hybridization.
Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
[TBL] [Abstract] [Full Text] [Related]
2. ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies.
Zammarchi F; Havenith KE; Sachini N; Janghra N; Chivers S; Idusogie E; Gaudio E; Tarantelli C; Bertelli F; Santos K; Tyrer P; Corbett S; Spriano F; Golino G; Cascione L; Bertoni F; Hartley JA; van Berkel PH
Mol Cancer Ther; 2024 Apr; 23(4):520-531. PubMed ID: 38324336
[TBL] [Abstract] [Full Text] [Related]
3. Multifaceted roles for bcl3 in cancer: a proto-oncogene comes of age.
Seaton G; Smith H; Brancale A; Westwell AD; Clarkson R
Mol Cancer; 2024 Jan; 23(1):7. PubMed ID: 38195591
[TBL] [Abstract] [Full Text] [Related]
4. Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective.
Karrs JX; Sathyanarayana SH; Xu X; Green DC; Kahn WA; Loo EY; Kaur P
J Hematop; 2023 Dec; 16(4):217-221. PubMed ID: 38175432
[TBL] [Abstract] [Full Text] [Related]
5. Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis.
Yong JH; Mai AS; Matetić A; Elbadawi A; Elgendy IY; Lopez-Fernandez T; Mamas MA
Am J Cardiol; 2024 Feb; 212():80-102. PubMed ID: 38042266
[TBL] [Abstract] [Full Text] [Related]
6. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
7. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever.
Kanda N; Yamaguchi R; Yamamoto Y; Matsumura M; Hatakeyama S
Sci Rep; 2023 Nov; 13(1):18784. PubMed ID: 37914769
[TBL] [Abstract] [Full Text] [Related]
8. Bcl-3 regulates T cell function through energy metabolism.
Liu H; Zeng L; Pan M; Huang L; Li H; Liu M; Niu X; Zhang C; Wang H
BMC Immunol; 2023 Oct; 24(1):35. PubMed ID: 37794349
[TBL] [Abstract] [Full Text] [Related]
9. BCL-3 Promotes Intracerebral Hemorrhage Progression by Increasing Blood-Brain Barrier Permeability, Inflammation, and Cell Apoptosis via Endoplasmic Reticulum Stress.
Yin H; Ran Z; Luo T; Jin Z; Ma J
Mediators Inflamm; 2023; 2023():1420367. PubMed ID: 37736616
[TBL] [Abstract] [Full Text] [Related]
10.
Carbo-Meix A; Guijarro F; Wang L; Grau M; Royo R; Frigola G; Playa-Albinyana H; Buhler MM; Clot G; Duran-Ferrer M; Lu J; Granada I; Baptista MJ; Navarro JT; Espinet B; Puiggros A; Tapia G; Bandiera L; De Canal G; Bonoldi E; Climent F; Ribera-Cortada I; Fernandez-Caballero M; De la Banda E; Do Nascimento J; Pineda A; Vela D; Rozman M; Aymerich M; Syrykh C; Brousset P; Perera M; Yanez L; Ortin JX; Tuset E; Zenz T; Cook JR; Swerdlow SH; Martin-Subero JI; Colomer D; Matutes E; Bea S; Costa D; Nadeu F; Campo E
Haematologica; 2024 Feb; 109(2):493-508. PubMed ID: 37560801
[TBL] [Abstract] [Full Text] [Related]
11. [Regulation of Baicalin on Growth of Extranodal NK/T Cell lymphoma Cells through FOXO3/
Duan XH; Li H; Lyu Y; Liu J; Wang SX; Wu ZT; Wang BX; Lu M; Wang JH; Liang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):730-738. PubMed ID: 37356933
[TBL] [Abstract] [Full Text] [Related]
12. Cardiovascular Toxicities Associated with Anaplastic lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase).
Niimura T; Miyata K; Hamano H; Nounin Y; Unten H; Yoshino M; Mitsuboshi S; Aizawa F; Yagi K; Koyama T; Goda M; Kanda Y; Izawa-Ishizawa Y; Zamami Y; Ishizawa K
Drug Saf; 2023 Jun; 46(6):545-552. PubMed ID: 37106270
[TBL] [Abstract] [Full Text] [Related]
13. Nomograms for predicting overall survival and cancer-specific survival in patients with head and neck non-Hodgkin lymphoma: A population-based study.
Peng J; Chen J; Liu Y; Lyu J; Zhang B
Medicine (Baltimore); 2023 Feb; 102(6):e32865. PubMed ID: 36820559
[TBL] [Abstract] [Full Text] [Related]
14. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract] [Full Text] [Related]
15. Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration - a Swedish nationwide retrospective study.
Lauppe R; Nilsson FOL; Fues Wahl H; Lilja M; Vikström A; T Asanin S
Acta Oncol; 2022 Nov; 61(11):1354-1361. PubMed ID: 36368902
[TBL] [Abstract] [Full Text] [Related]
16. Predictors of Secondary Lung Cancer Among Hodgkin lymphoma Survivors: A Nationwide Analysis.
Alnimer Y; Ali MKM
Clin Lung Cancer; 2022 Dec; 23(8):e510-e518. PubMed ID: 36008241
[TBL] [Abstract] [Full Text] [Related]
17. How can the rate of nontherapeutic thymectomy be reduced?
Wang S; Ao Y; Jiang J; Lin M; Chen G; Liu J; Zhao S; Gao J; Zhang Y; Ding J; Tan L
Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35579357
[TBL] [Abstract] [Full Text] [Related]
18. Molecular characterization, expression and anti-tumor function analysis of yak IFITM2 gene.
Wang H; Wang L; Luo X; Guan J; Zhang X; Zhang L; Xiang Y
Int J Biol Macromol; 2022 Jun; 209(Pt A):405-412. PubMed ID: 35381283
[TBL] [Abstract] [Full Text] [Related]
19. Bcl-3: A Double-Edged Sword in Immune Cells and Inflammation.
Liu H; Zeng L; Yang Y; Guo C; Wang H
Front Immunol; 2022; 13():847699. PubMed ID: 35355979
[TBL] [Abstract] [Full Text] [Related]
20. Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States.
Alrawashdh N; McBride A; Slack M; Persky D; Andritsos L; Abraham I
J Manag Care Spec Pharm; 2022 Apr; 28(4):390-400. PubMed ID: 35332792
[No Abstract] [Full Text] [Related]
[Next]